TY - JOUR
T1 - APC transcription studies and molecular diagnosis of familial adenomatous polyposis
AU - Short, Emma
AU - Thomas, Laura E.
AU - Davies, Alice
AU - Bolton, Alice
AU - Maynard, Julie
AU - Giles, Peter
AU - Mort, Matthew
AU - Consoli, Claudia
AU - Egner, Iris
AU - Jundi, Hala
AU - Sampson, Julian R.
N1 - Publisher Copyright:
© 2019, European Society of Human Genetics.
PY - 2019/8/5
Y1 - 2019/8/5
N2 - Familial adenomatous polyposis (FAP) is characterised by the development of hundreds to thousands of colorectal adenomas and results from inherited or somatic mosaic variants in the APC gene. Index patients with suspected FAP are usually investigated by APC coding region sequence and dosage analysis in a clinical diagnostic setting. The identification of an APC variant which is predicted to alter protein function enables predictive genetic testing to guide the management of family members. This report describes a 4-generation family with a phenotype consistent with FAP, but in which an APC variant had not been identified, despite testing. To explore this further, quantitative PCR (qPCR) was employed to assess APC transcription, demonstrating reduced levels of APC RNA. Next generation sequencing (NGS) identified the APC 5′UTR/ Exon 1 variant, c.-190 G>A, that had been reported previously in an another FAP family with APC allelic imbalance. Quantitative RNA studies and DNA sequencing of the APC promoters/ Exon 1 may be useful diagnostically for patients with suspected FAP when coding region variants cannot be identified.
AB - Familial adenomatous polyposis (FAP) is characterised by the development of hundreds to thousands of colorectal adenomas and results from inherited or somatic mosaic variants in the APC gene. Index patients with suspected FAP are usually investigated by APC coding region sequence and dosage analysis in a clinical diagnostic setting. The identification of an APC variant which is predicted to alter protein function enables predictive genetic testing to guide the management of family members. This report describes a 4-generation family with a phenotype consistent with FAP, but in which an APC variant had not been identified, despite testing. To explore this further, quantitative PCR (qPCR) was employed to assess APC transcription, demonstrating reduced levels of APC RNA. Next generation sequencing (NGS) identified the APC 5′UTR/ Exon 1 variant, c.-190 G>A, that had been reported previously in an another FAP family with APC allelic imbalance. Quantitative RNA studies and DNA sequencing of the APC promoters/ Exon 1 may be useful diagnostically for patients with suspected FAP when coding region variants cannot be identified.
UR - http://www.scopus.com/inward/record.url?scp=85070227208&partnerID=8YFLogxK
U2 - 10.1038/s41431-019-0486-2
DO - 10.1038/s41431-019-0486-2
M3 - Article
C2 - 31383941
AN - SCOPUS:85070227208
SN - 1018-4813
VL - 28
SP - 118
EP - 121
JO - European Journal of Human Genetics
JF - European Journal of Human Genetics
IS - 1
ER -